INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2011
Total net assets |
£103.6m |
NAV per share |
176.2p |
Share price |
153.0p |
Total value of unquoted investments |
£25.2m |
Total number of portfolio companies |
58 |
Cash |
(1)% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
11% NAV |
Top Ten Holdings
Company Name |
% NAV |
Shire Ltd |
5.89 |
Celgene |
5.88 |
Cadent |
5.48 |
Gilead Sciences |
5.17 |
Amgen |
4.95 |
Insulet |
4.74 |
Teva |
4.28 |
Micromet |
3.49 |
Vertex |
3.23 |
Alexion |
3.01 |
|
----------- |
Total |
46.12 |
Geographical Allocation |
% |
United States |
70 |
Europe |
25 |
Middle East |
4 |
Australia |
2 |
Cash |
(1) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
77 |
Unquoted |
24 |
Cash |
(1) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 APRIL 2011